Expert Comparison: Wegovy vs Mounjaro Online Prescription
What's Best Between Wegovy or Mounjaro: Online Prescription Advantages
When deciding what's best between Wegovy or Mounjaro, accessing expert medical guidance shouldn't require weeks of waiting for GP appointments or specialist referrals. Our online prescription service connects you directly with licensed UK prescribers who specialise in weight management treatments, eliminating traditional healthcare barriers that delay treatment access. The 3-minute clinical assessment covers your complete medical history, current medications, previous weight loss attempts, and specific contraindications for both semaglutide and tirzepatide.
This streamlined approach means you can compare what's best between Wegovy or Mounjaro with professional medical oversight whilst maintaining complete privacy and convenience. Our prescribers don't simply approve or reject applications - they provide personalised recommendations based on your individual clinical profile, explaining why one treatment might be more suitable than the other. Express approval is available within 24 hours for patients requiring urgent treatment commencement, whilst standard reviews are completed within 3 working days.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the financial commitment helps determine what's best between Wegovy or Mounjaro for your budget and treatment timeline. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Mounjaro follows a different pricing structure reflecting its dual-agonist formulation and dosing schedule. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices.
Our bundle options provide treatment continuity rather than cost savings, with the Intro Trio (0.25mg, 0.5mg, 1mg Wegovy) available for £299.99 and the Ultimate Stability Trio (three 2.4mg pens) for £649.99. When comparing what's best between Wegovy or Mounjaro financially, consider the complete dose escalation journey rather than individual pen prices. Both treatments require gradual dose increases to minimise gastrointestinal side effects, making bundle purchases practical for ensuring uninterrupted treatment progression. Your prescriber will outline the expected treatment duration and total investment during the clinical consultation.
Clinical Evidence: What's Best Between Wegovy or Mounjaro
Determining what's best between Wegovy or Mounjaro requires understanding their distinct clinical trial results, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent efficacy across different patient groups, including those with type 2 diabetes and varying baseline BMI levels.
Mounjaro's SURMOUNT trials showed the dual GIP and GLP-1 receptor agonist mechanism may produce different weight loss patterns, though comparing percentages directly would be misleading given the different study protocols and endpoints. When evaluating what's best between Wegovy or Mounjaro, your prescriber considers your medical history, concurrent medications, and individual risk factors rather than relying solely on population-level trial data. Both treatments demonstrated cardiovascular benefits in their respective studies, with Wegovy's SELECT trial showing a 20% reduction in major cardiovascular events.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone responsible for post-meal satiety signalling. This mechanism works primarily in the hypothalamus, reducing appetite signals and increasing feelings of fullness after smaller meals, which may help patients achieve sustainable calorie reduction without constant hunger. The once-weekly injection maintains steady semaglutide levels, providing consistent appetite regulation throughout the seven-day dosing interval. Unlike rapid-acting appetite suppressants, Wegovy's mechanism focuses on normalising hunger and satiety cues rather than creating artificial appetite suppression. The treatment works alongside reduced-calorie diet and increased physical activity, enhancing your natural weight management efforts rather than replacing healthy lifestyle changes. Understanding this mechanism helps explain why Wegovy requires gradual dose escalation and why weight regain occurs if treatment discontinues without maintained lifestyle modifications.
Ordering Process: From Assessment to Delivery
Getting your Wegovy or Mounjaro prescription begins with our comprehensive 3-minute clinical assessment covering medical history, current medications, previous weight loss attempts, and specific contraindications for GLP-1 treatments. Licensed UK prescribers review every submission individually, often requesting additional information or suggesting alternative approaches based on your clinical profile rather than providing automated approvals. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) with next-day delivery using temperature-controlled packaging to maintain the cold-chain requirements. Express processing is available for £15 additional, reducing approval times to 24 hours for patients requiring immediate treatment commencement. The entire process eliminates GP visits, specialist referrals, and pharmacy queues whilst maintaining full medical oversight and regulatory compliance. Your prescriber remains available for dose adjustment consultations and side effect management throughout your treatment journey.
Storage and Practical Considerations
Wegovy requires refrigeration at 2-8°C before first use but offers superior travel convenience with 6 weeks room temperature stability below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen system provides precise dosing with an easy-to-use injection mechanism suitable for self-administration, with most patients reporting minimal injection discomfort after the first few doses. Dose escalation follows a mandatory schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. This gradual increase minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's appetite-regulating effects. Planning international travel requires consideration of the refrigeration requirements, though the 6-week room temperature stability provides flexibility for extended trips. Each pen contains four weekly doses, with the injection site rotated between thigh, abdomen, or upper arm to prevent lipodystrophy.
What's Best Between Wegovy or Mounjaro: Personalised Online Assessment
The question of what's best between Wegovy or Mounjaro cannot be answered universally, as individual medical histories, concurrent medications, and treatment goals significantly influence prescriber recommendations. Our online clinical assessment specifically evaluates factors that might favour one treatment over another, including previous GLP-1 experience, gastrointestinal sensitivity, cardiovascular history, and concurrent diabetes management. Unlike generic consultations, this assessment provides personalised guidance explaining why your prescriber recommends Wegovy or Mounjaro based on your specific clinical profile.
This individualised approach proves particularly valuable for patients with complex medical histories or those taking multiple medications where drug interactions might influence treatment selection. The online format allows thorough consideration of your medical history without the time pressures of traditional GP appointments, resulting in more comprehensive treatment recommendations. Both treatments are available through our service, ensuring your prescriber can recommend what's genuinely best between Wegovy or Mounjaro rather than being limited by formulary restrictions or supply issues common in traditional healthcare settings.
Start Your Weight Management Journey Today
Begin your comparison of what's best between Wegovy or Mounjaro with our expert online prescription service, starting at £79.99 with code FIRST40 for new customers or DOSE25 for returning patients. Our licensed prescribers provide individualised recommendations based on comprehensive medical assessment rather than one-size-fits-all approaches, ensuring you receive the most appropriate treatment for your circumstances. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and receive expert guidance on whether Wegovy or Mounjaro aligns better with your weight management goals. Both prescription-only medicines are available with next-day delivery from our GPhC-registered pharmacy, providing immediate access to medically supervised weight management treatment. Express approval ensures you can start your chosen treatment within 24 hours, eliminating the delays associated with traditional healthcare pathways whilst maintaining complete medical oversight and safety standards.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
